by Gorry » Fri Feb 07, 2014 10:19 pm
Found this... it's a pay site, so here's what I can find out for free:Sales for Celebrx rank 20th among ALL prescription drugs(pretty impressive, eh?) with annual sales in 07 at $1,416,084,000Applicant Ingredient NDA Number Approval Date Type Patent Number Patent Expiration Exclusivity Expiration Patented / Exclusive Use Gd Searle celecoxib 020998 003 Aug 29, 2002 RX Dec 15, 2009 NEW PATIENT POPULATION Gd Searle celecoxib 020998 001 Dec 31, 1998 RX 5,466,823*PED May 30, 2014 Gd Searle celecoxib 020998 003 Aug 29, 2002 RX Jan 29, 2009 PEDIATRIC EXCLUSIVITY Gd Searle celecoxib 020998 003 Aug 29, 2002 RX Jul 29, 2008 FOR RELIEF OF THE SIGNS AND SYMPTOMS OF ANKYLOSING SPONDYLITIS Gd Searle celecoxib 020998 003 Aug 29, 2002 RX 5,972,986*PED Apr 14, 2018 Wow... that didn't copy over very well... here's the info link:http://www.drugpatentwatch.com/premium/preview/detail/index.php?searchtype=alpha&category=Tradename&searchstring=CELEBREXThere can be more than one patent for a single drub based on the application of is to certain, specialized uses, pediatric use, etc. There are also "exclusive uses" granted which prohibit other pharmaceuticals from using a "generic" or similar drug for that specific purpose.From what I gather on that site, Celebrex has two patents. One which expires May 30, 2014 and a second which expires August 14, 2018